Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.
Journal: JCO precision oncology
Published: January 31, 2025
Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer.
Journal: Breast cancer (Dove Medical Press)
Published: April 01, 2024
Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer.
Journal: European journal of endocrinology
Published: September 17, 2015
An assessment of opinion of Indian physicians about emergency medicine in India.
Journal: The National medical journal of India
Published: September 12, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026